Precision Biosciences (DTIL) Shares Outstanding (2018 - 2026)

Precision Biosciences (DTIL) has 8 years of Shares Outstanding (Entity) data on file, last reported at $12.8 million in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 87.71% year-over-year to $12.8 million in Q4 2025; TTM through Dec 2025 was $12.8 million, a 87.71% increase from a year earlier, with the FY2025 full-year figure at $12.8 million, up 87.71% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $12.8 million, up from $12.1 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for DTIL reached as high as $12.8 million in Q4 2025 and fell as low as $1.9 million in Q1 2021.
• Historically, Shares Outstanding (Entity) has averaged $5.4 million across 5 years, with a median of $3.9 million in 2023.
• Across the five-year window, Shares Outstanding (Entity) advanced 4.25% in 2023 and soared 108.97% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $2.1 million in 2021, then surged by 42.43% to $2.9 million in 2022, then surged by 43.06% to $4.2 million in 2023, then jumped by 63.04% to $6.8 million in 2024, then soared by 87.71% to $12.8 million in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $12.8 million in Q4 2025, $12.1 million in Q3 2025, and $11.7 million in Q2 2025.